Depressiv-ängstliche Störungen bei somatischen Krankheiten

  • H.-P. Kapfhammer


  1. Ammon Cavanaugh S von (1984) Diagnosing depression in the hospitalized patient with chronic medical illness. J Clin Psychiatry 45:13–16Google Scholar
  2. Ammon Cavanaugh S von (1995) Depression in the medically ill. Critical issues in diagnostic assessment. Psychosomatics 36:48–59Google Scholar
  3. Ananth J (1974) Antiasthmatic effect of amitriptyline. Can Med Assoc J 110:1133Google Scholar
  4. Ananth J, Swartz R, Burgoyne K et al. (1994) Hepatic disease and psychiatric illness. Psychother Psychosom 62:146–159PubMedGoogle Scholar
  5. Andersen J, Aabro E, Gulman N (1980) Antidepressant treatment in parkinson’s disease. Acta Neurol Scand 62:210–219PubMedGoogle Scholar
  6. Aronoff G, Bergstrom R, Pottratz S et al. (1984) Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin Pharmacol Ther 36:138–144PubMedGoogle Scholar
  7. Baldessarini RJ (1996) Drugs and the treatment of psychiatric disorders. Depression and mania. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill, New York, p 431Google Scholar
  8. Bandelow B, Rüther E (1993) Besonderheiten der Psychopharmakatherapie bei psychisch Kranken mit körperlichen Erkrankungen. In:Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Enke, Stuttgart, S 791–800Google Scholar
  9. Bass S, Colebatch H (1992) Fluoxetine-induced lung damage (letter). Med J Aust 156:364–365PubMedGoogle Scholar
  10. Beckson M, Cummings JL (1992) Neuropsychiatric aspects of stroke. Int J Psychiatry Med 21:1–15Google Scholar
  11. Beitman BD, Mukerji J, Lamberti JW et al. (1989) Panic disorder in patients with chest pain and angiographically normal coronary arteries.Am J Cardiol 63:1399–1403CrossRefPubMedGoogle Scholar
  12. Bergstrom R, Beasley C, Levy N et al. (1993) The effect of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine. Int Clin Psychopharmacol 8:261–266PubMedGoogle Scholar
  13. Berrios GE, Quemada JI (1990) Depressive illness in multiple sclerosis. Br J Psychiatry 156:10–16PubMedGoogle Scholar
  14. Beutel M, Weiner H (1993) Trauer und Depression nach einem Objektverlust. Forum Psychoanal 9:224–239Google Scholar
  15. Bigger JT, Fleiss JL, Steinman RC et al. (1992) Frequency domain measures of heart rate period variability and mortality after myocardial infarction. Circulation 85:164–171PubMedGoogle Scholar
  16. Bishay NR, Tarrier N, Roberts AP (1995) Cognitive therapy of agoraphobia in reaction to physical illness: An uncontrolled study. Ir J Psychol Med 12:135–138Google Scholar
  17. Blackwell B (1981) Adverse effects of antidepressant drugs. Drugs 21:201–219PubMedGoogle Scholar
  18. Bluestine S, Lesko L (1994) Psychotropic medications in oncology and in AIDS patients.Adv Psychosom Med 21:107–137PubMedGoogle Scholar
  19. Borson S, McDonald G, Gayle T et al. (1992) Improvement in mood, physical symptoms, and functions with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190–201PubMedGoogle Scholar
  20. Bouckoms A, Hackett TP (1991) The pain patient: Evaluation and treatment. In: Cassem N (ed) Massachusetts General Hospital Handbook of General Hospital Psychiatry, 3rd edn. Mosby Year Book, St. Louis, pp 39–68Google Scholar
  21. Brosen K (1996) Are pharmacokinetic drug interactions with the SSRI an issue? Int Clin Psychopharmacol 11(Suppl 1):23–27PubMedGoogle Scholar
  22. Brown JH, Paraskevas F (1982) Cancer and depression: Cancer presenting with depressive illness: An autoimmune disease? Br J Psychiatry 141:227–232PubMedGoogle Scholar
  23. Brown RG, MacCarthy B, Gotham AM et al. (1988) Depression and disability in Parkinson’s disease. Psychol Med 18:49–55PubMedGoogle Scholar
  24. Brown TM, Stoudemire A, Fogel BS, Moran MG (2000) Psychopharmacology in the medical patient. In: Stoudemire A, Fogel BS Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 329–372Google Scholar
  25. Bukberg J, Penman D, Holland JS (1984) Depression in hospitalized cancer patients. Psychosom Med 46:199–212PubMedGoogle Scholar
  26. Burvill PW, Johnson GA, Vamrozik KD et al. (1995) Anxiety disorders after stroke: Results from the Perth Community Stroke Study. Br J Psychiatry 166:328–332PubMedGoogle Scholar
  27. Callies AL, Popkin MK (1987) Antidepressant treatment in medical-surgical inpatients by nonpsychiatric physicians. Arch Gen Psychiatry 44:157–160PubMedGoogle Scholar
  28. Cassem EH (1988) Depression secondary to medical illness. Rev Psychiatry 7:256–273Google Scholar
  29. Cassem EH (1990) Depression and anxiety secondary to medical illness. Psychiatr Clin North Am 13:597–612PubMedGoogle Scholar
  30. Cassem EH (1995) Depressive disorders in the medically ill. Psychosomatics 36:2–10Google Scholar
  31. Castiella A, Arenas J (1994) Fluoxetine hepatotoxicity (letter). Am J Gastroenterol 89:458–459PubMedGoogle Scholar
  32. Chiarello RJ, Cole JO (1987) The use of psychostimulants in general psychiatry: A reconsideration. Arch Gen Psychiatry 44:286–295PubMedGoogle Scholar
  33. Chochinov HM, Wilson KG, Enns M et al. (1994) Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgements. Am J Psychiatry 4:537–540Google Scholar
  34. Ciraulo DA, Shader RI (1990a) Fluoxetine drug-drug interactions, I. Antidepressants and antipsychotics. J Clin Psychopharmacol 10:48–50PubMedGoogle Scholar
  35. Ciraulo DA, Shader RI (1990b) Fluoxetine drug-drug interactions, II. J Clin Psychopharmacol 10:213–217PubMedGoogle Scholar
  36. Clark DC, von Ammon Cavanaugh S, Gibbons RD (1983) The core symptoms of depression in medical and psychiatric patients. J Nerv Ment Dis 171:705–713PubMedGoogle Scholar
  37. Clark DA, Cook A, Snow D (1998) Depressive symptom differences in hospitalized, medically ill, depressed psychiatric inpatients and nonmedical controls. J Abnorm Psychol 107:38–48CrossRefPubMedGoogle Scholar
  38. Clayton PJ, Lewis CE (1981) The significance of secondary depression. J Affect Disord 3:25–35CrossRefPubMedGoogle Scholar
  39. Cohen-Cole SA, Stoudemire A (1987) Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am 10:1–17PubMedGoogle Scholar
  40. Colon EA, Popkin MK (1996) Anxiety and panic. In: Randell JR, Wise MG (eds) Textbook of consultation-liaison psychiatry. American Psychiatric Press, Washington/DC, pp 402–425Google Scholar
  41. Costa D, Mogos I, Toma T (1985) Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 72(Suppl 329):85–92Google Scholar
  42. Coulehan JI, Schulberg HC, Block MR, Zettler-Segal M (1988) Symptom patterns of depression in ambulatory medical and psychiatric patients. J Nerv Ment Dis 176:284–288PubMedGoogle Scholar
  43. Craven JL, Rodin GM, Johnson L, Kennedy SH (1987) The diagnosis of major depression in renal dialysis patients. Psychosom Med 49:482–492PubMedGoogle Scholar
  44. Creed F (1997) Assessing depression in the context of physical illness. In: Robertson MM, Katona CLE (eds) Depression and physical illness. Wiley & Sons, Chichester, pp 3–19Google Scholar
  45. Cull A (1990) Invited review: Psychological aspects of cancer and chemotherapy. J Psychosom Res 34:129–140CrossRefPubMedGoogle Scholar
  46. Cummings JL (1992) Depression and Parkinson’s disease. Am J Psychiatry 149:443–454PubMedGoogle Scholar
  47. Dalack GW, Roose SP (1990) Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 51(Suppl):4–9PubMedGoogle Scholar
  48. Dawling S, Lynn K, Rosser R et al. (1982) Nortriptyline metabolism in chronic renal failure: Metabolite elimination. Clin Pharmacol Ther 32:322–329PubMedGoogle Scholar
  49. De Vito AJ (1990) Dyspnoe during hospitalizations for acute phase of illness as recalled by patients with chronic obstructive airway disease. Heart Lung 19:186–191Google Scholar
  50. Derogatis LR, Wise TN (eds) (1989) Anxiety and depressive disorders in the medical patient. American Psychiatric Press, Washington, DCGoogle Scholar
  51. Derogatis LR, Morrow GR, Fetting J et al. (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757CrossRefPubMedGoogle Scholar
  52. Deshpande SN, Sundaram KR, Wig NN (1989) Psychiatric disorders among medical inpatients in an Indian hospital. Br J Psychiatry 154:504–509PubMedGoogle Scholar
  53. Dew MA, Ragi MV, Nimorwicz P (1990) Infection with human immunodeficiency virus and vulnerability to psychiatric distress. Arch Gen Psychiatry 47:737–744PubMedGoogle Scholar
  54. Dietch J (1981) Diagnosis of organic anxiety. Psychosomatics 22:661–665PubMedGoogle Scholar
  55. Dietch J, Fine M (1990) The effect of nortriptyline in elderly patients with cardiac conduction disease. J Clin Psychiatry 51:65–67PubMedGoogle Scholar
  56. Doyle G, Laher M, Kelly J et al. (1989) The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatr Scand 80(Suppl 350):89–90Google Scholar
  57. Drossman DA, Thompson WG (1992) The irritable bowel syndrome: Review and a graduated multicomponent treatment approach. Ann Intern Med 116:1009–1016PubMedGoogle Scholar
  58. Ehrentraut S, Rothenhäusler HB, Gerber A, Rau HG, Thiel M, Schirren CA (2000) Akutes Leberversagen unter Nefazodon-Therapie? Nervenarzt 73:686–689Google Scholar
  59. Eilenberg MD (1960) Psychiatric illness and pernicious anemia. J Ment Sci 106:1539–1548Google Scholar
  60. Epstein SA (1994) Psychotropic medications in gastrointestinal and hepatic disease. In: Silver P (ed) Psychotropic drug use in the medically ill. Adv Psychosom Med, vol 21. Karger, Basel, pp 49–60Google Scholar
  61. Ereshefsky L (1996) Drug interactions of antidepressants. Psychiatr Ann 26:342–350Google Scholar
  62. Evans M, Hammond M, Wilson K et al. (1997) Placebo-controlled treamtent trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 12:817–824PubMedGoogle Scholar
  63. Fava GA (1994) Affective disorders and endocrine disease. New insights from psychosomatic studies. Psychosomatics 35:341–353PubMedGoogle Scholar
  64. Fava GA, Molnar G (1987) Criteria for diagnosing depression in the setting of medical disesase. Psychother Psychosom 48:21–25PubMedGoogle Scholar
  65. Fava GA, Sonino N (1996) Depression associated with medical illness. CNS Drugs 5:175–189Google Scholar
  66. Fava GA, Sonino N, Morphy MA (1993) Psychosomatic view of endocrine disorders. Psychother Psychosom 59:20–33PubMedGoogle Scholar
  67. Fava GA, Trombini G, Barbara L et al. (1985) Depression and gastrointestinal illness: The joint use of biological and clinical criteria. Am J Gastroenterol. 80:195–199PubMedGoogle Scholar
  68. Fava GA, Sonino N, Wise TN (1988) Management of depression in medical patients. Psychother Psychosom 49:81–102PubMedGoogle Scholar
  69. Fava M, Rosenbaum JF, Pava J et al. (1993) Anger attacks in unipolar depression, part 1: Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 150:1153–1163Google Scholar
  70. Fawzy FI, Fawzy NW, Hyun CS et al. (1993) Malignant melanome: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681–689PubMedGoogle Scholar
  71. Fawzy FI, Fawzy NW, Canada AL (1998) Psychosocial treatment of cancer: An update. Curr Opin Psychiatry 11:601–605CrossRefGoogle Scholar
  72. Feldman E, Mayou R, Hawton K et al. (1987) Psychiatric disorder in medical inpatients. QJM 63:405–412PubMedGoogle Scholar
  73. Fernandes NF, Martin RR, Schenker S (2000) Trazodone-induced hepatotoxicity. A case report with comment on drug-induced hepatotoxicity. Am J Gastroenterol 95:532–538PubMedGoogle Scholar
  74. Fifer SK, Mathias SD, Patrick DL et al. (1994) Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 51:740–750PubMedGoogle Scholar
  75. Fogel BS (1990) Major depression versus organic mood disorder: A questionable distinction. J Clin Psychiatry 51:53–56PubMedGoogle Scholar
  76. Folstein SE, Abbott MH, Chase GA et al. (1983) Huntington’s disease in a case series and in a family. Psychol Med 13:537–542PubMedGoogle Scholar
  77. Ford MF (1986) Treatment of depression in Huntington’s disease with monoamine oxidase inhibitors. Br J Psychiatry 149:654–656PubMedGoogle Scholar
  78. Frank RG, Beck NC, Parker JC et al. (1988) Depression in rheumatoid arthritis. J Rheumatol 15:920–925PubMedGoogle Scholar
  79. Frasure-Smith N (1991) In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. Am J Cardiol 67:121–127CrossRefPubMedGoogle Scholar
  80. Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction, impact on 6-month survival. JAMA 270:1819–1825CrossRefPubMedGoogle Scholar
  81. Freedland KE, Carney RM, Lustman PJ et al. (1992) Major depression in coronary artery disease patients with vs. without prior history of depression. Psychosom Med 54:416–421PubMedGoogle Scholar
  82. Gellert GA, Maxwell RM, Siegel BS (1993) Survival of breast cancer patients receiving adjunctive psychosocial support therapy: A 10-year follow-up study. J Clin Oncol 11:66–69PubMedGoogle Scholar
  83. Goldberg RJ, Posner DA (1993) Anxiety in the medically ill. In: Stoudemire A, Fogel BS (eds) Psychiatric care of the medical patient. Oxford University Press, New York, pp 87–104Google Scholar
  84. Gonzalez-Rothi R, Zander D, Ros P (1995) Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 107:1763–1765PubMedGoogle Scholar
  85. Goodnick PJ (1994) The pharmacokinetic optimization of treatment with newer antidepressants. Clin Pharmacokinet 27:307–330PubMedGoogle Scholar
  86. Gore-Felton C, Spiegel D (2000) Group psychotherapy for medically ill patients. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 41–49Google Scholar
  87. Greer S (1994) Psycho-oncology: Its aims, achievements, and future tasks. Psychooncology 3:87–101Google Scholar
  88. Guthrie E (1996) Emotional disorders in chronic illness: Psychotherapeutic interventions. Br J Psychiatry 168:265–273PubMedGoogle Scholar
  89. Haggerty JJ, Drossman DA (1985) Use of psychotropic drugs in patients with peptic ulcer. Psychosomatics 26:277–284PubMedGoogle Scholar
  90. Hama N, Boumpas DTD (1995) Cerebral lupus erythematosus. CNS Drugs 3:416–426Google Scholar
  91. Harrison J, Maguire P (1994) Predictors of psychiatric morbidity in cancer patients. Br J Psychiatry 165:593–598PubMedGoogle Scholar
  92. Hayward C, Clark DB, Taylor CB et al. (1990) Panic disorder, anxiety, and cardiovascular risk. In: Ballenger JC (ed) Clinical aspects of panic disorder. Wiley-Liss, New York, pp 99–110Google Scholar
  93. Henry JA (1989) A fatal toxicity index for antidepressant poisoning. Acta Psychiatr Scand 80:37–45Google Scholar
  94. Hinrichsen GA, Liebermann JA, Pollack S et al. (1989) Depression in hemodialysis patients. Psychosomatics 30:284–289PubMedGoogle Scholar
  95. Holland JC, Hughes A, Korzan AH et al. (1986) Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 143:982–986PubMedGoogle Scholar
  96. Holliday SM, Benfield P (1995) Venlafaxine A review of its pharmacology and therapeutic potential in depression. Drugs 49:280–294PubMedGoogle Scholar
  97. Horowitz MJ (1976) Stress response syndromes. Jason Aronson, New YorkGoogle Scholar
  98. Horowitz MJ, Siegel B, Holen A et al. (1997) Diagnostic criteria for complicated grief disorder. Am J Psychiatry 154:904–910PubMedGoogle Scholar
  99. Hughes JE (1985) Depressive illness and lung cancer. Eur J Surg Oncol 11:15–20PubMedGoogle Scholar
  100. Judd FK, Mijch AM (1994) Depression in patients with HIV and AIDS. Aust NZ. J Psychiatry 28:642–650Google Scholar
  101. Kaasa S, Malt U, Jagen S et al. (1993) Psychological distress in cancer patients with advanced disease. Radiotherp Oncol 27:192–197Google Scholar
  102. Kapfhammer HP (1993a) Epidemiologie der Depression im Rahmen von Tumorerkrankungen. In: Staab HJ, Ludwig M (Hrsg) Depression bei Tumorpatienten. Thieme, Stuttgart, S 29–41Google Scholar
  103. Kapfhammer HP (1993b) Nieren-und leberinsuffiziente Patienten — ein therapeutisches Problem. In: Möller HJ, Przuntek H (Hrsg) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin Heidelberg New York Tokyo, S 75–92Google Scholar
  104. Kapfhammer HP (1995) Benzodiazepine bei Angsterkrankungen. In: Kasper S, Möller HJ (Hrsg) Praxis der Angst-und Panikerkrankungen. Fischer, Stuttgart, S 261–288Google Scholar
  105. Kapfhammer HP (1996) Depression und Suizidalität bei Krebserkrankungen. TW Neurologie Psychiatrie 10:281–283Google Scholar
  106. Kapfhammer HP (1998) Internistische Aspekte der Behandlung mit Antidepressiva. In: Hewer W, Lederbogen F (Hrsg) Internistische Probleme bei psychiatrischen Erkrankungen. Enke, Stuttgart, S 51–87Google Scholar
  107. Kapfhammer HP (1999) Psychopharmakotherapie depressiver Störungen bei somatischen Erkrankungen mit selektiven Serotonin-Wiederaufnahmehemmern, anderen neueren Antidepressiva und amphetaminergen Substanzen. In: Diefenbacher A (Hrsg) Aktuelle Konsiliarpsychiatrie und-psychotherapie. Thieme, Stuttgart, S 131–160Google Scholar
  108. Kapfhammer HP (2001) Begleitdepression bei körperlichen Krankheiten: Epidemiologie und Diagnostik. Jatros Neurologie/Psychiatrie (Sonderpublikation):6–17Google Scholar
  109. Kapfhammer HP (2002) Organisch depressive Störungen: Koronare Herzerkrankung, Diabetes mellitus, Krebs. In: Laux G (Hrsg) Depression 2000. Springer, Berlin Heidelberg New York Tokyo, S 65–86Google Scholar
  110. Kapfhammer HP, Rothenäusler HB, Krauseneck T, Stoll C, Schelling G (2001) Posttraumatische Belastungsstörung bei Patienten mit ARDS. Jahrbuch der Medizinischen Psychologie 20. Hogrefe, Göttingern, Bern, Toronto, Seattle, S 119–138Google Scholar
  111. Kathol RG, Wenzel RP (1992) Natural history of symptoms of depression and anxiety during inpatient treatment on general medicine wards. J Gen Int Med 7:287–293Google Scholar
  112. Kathol RG, Turner R, Delahunt J (1986) Depression and anxiety associated with hyperthyroidism: Response to antithyroid therapy. Psychosomatics 27:501–505PubMedGoogle Scholar
  113. Kathol RG, Mulgi A, Williams J et al. (1990) Diagnoss of major depression in cancer patients according to four stes of criteria. Am J Psychiatry 1021–1024Google Scholar
  114. Katon W (1998) The effect of major depression on chronic medical illness. Semin Clin Neuropsychiatry 2:82–86Google Scholar
  115. Katon W, Sullivan DM (1990) Depression and chronic medical illness, J Clin Psychiatry 51(Suppl 6):3–11PubMedGoogle Scholar
  116. Katon W, Berg AO, Robins AJ, Risse S (1986) Depression: Medical utilization and somatization. West J Med 114:564–568Google Scholar
  117. Katz IR (1996) On the inseparability of mental and physical health in aged persons. Am J Geriatr Psychiatry 4:1–6Google Scholar
  118. Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions: An integrative hypothesis. Arch Gen Psychiatry 50:306–317PubMedGoogle Scholar
  119. Klein E, Cnaani E, Harel T et al.(1995) Altered heart rate variability in panic disorder patients. Biol Psychiatry 37:18–24PubMedGoogle Scholar
  120. Klerman GL (1981) Depression in the medically ill. Psychiatr Clin North Am 4:301–317PubMedGoogle Scholar
  121. Koenig HG, Breitner JCC (1990) Use of antidepressants in medically old patients. Psychosomatics 31:22–32PubMedGoogle Scholar
  122. Koenig HG, Meador KG, Cohen HJ et al. (1988) Self-rated depression scales and screening for major depression in the older hospitalized patient with medical illness. J Am Geriatr Med 36:699–706Google Scholar
  123. Koenig HG, Georage LK, Meador KG (1997) Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients. Am J Psychiatry 154:1369–1375PubMedGoogle Scholar
  124. Koenig HG, Pappas P, Hoslinger T et al. (1995) Assessing diagnostic approaches to depression in medically ill older adults: How reliably can mental health professions make judgements about the cause or symptoms? J Am Geriatr Soc 43:472–478PubMedGoogle Scholar
  125. Korff M von, Shapiro S, Burke JD et al. (1987) Anxiety and depression in a primary care clinic: Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry 44:152–156Google Scholar
  126. Korff M von, Ormel H, Katon W et al. (1992) Disability and depression among high utilizers of health care: A longitudinal analysis. Arch Gen Psychiatry 49:91–100Google Scholar
  127. Larcombe NA, Wilson PH (1984) An evaluation of cognitive behavior therapy for depression in patients with multiple sclerosis. Br J Psychiatry 145:366–371PubMedGoogle Scholar
  128. Leipzig RM (1990) Psychopharmacology in patients with hepatic and gastrointestinal disease. Int J Psychiatry Med 22:109–139Google Scholar
  129. Lesko LM, Massie MJ, Holland J (1993) Oncology. In: Stoudemire A, Fogel (eds) Psychiatric care of the medical patient. Oxford University Press, Oxford New York Toronto, pp 565–590Google Scholar
  130. Levenson H, Hales RE (1993) Brief psychodynamically informed therapy for medically ill patients. In: Stoudemire A, Fogel BS (eds) Medical-psychiatric practice, vol 2. American Psychiatric Press, Washington/DC London, pp3–37Google Scholar
  131. Levenson H, Servis M, Hales RE (2000) Brief psychodynamic therapy in the medically ill. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 17–30Google Scholar
  132. Levenson J (1992) Psychosocial interventions in chronic medical illness. Gen Hosp Psychiatry 14:43–49CrossRefGoogle Scholar
  133. Levenson JL, Bemis C (1991) The role of psychological factors in cancer onset and progression. Psychosomatics 32:124–132PubMedGoogle Scholar
  134. Levenson JL, Friedel RO (1985) Major depression in patients with cardiac disease. Psychosomatics 26:91–102PubMedGoogle Scholar
  135. Levy N (1990) Psychopharmacology in patients with renal failure. Int J Psychiatry Med 20:325–334PubMedGoogle Scholar
  136. Liang LP, Dunn SM, Gorman A, Stuart-Harris R (1990) Identifying priorities of psychoocial need in cancer patients. Br J Cancer 62:1000–1003PubMedGoogle Scholar
  137. Lieberman JA, Cooper TB, Suckow RW et al. (1985) Tricyclic antidepressant and metabolite levels in chronic renal failure. Clin Pharmacol Ther 37:301–307PubMedGoogle Scholar
  138. Light RW, Merrill EJ, Despars J et al. (1986) Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 146:1377–1380CrossRefPubMedGoogle Scholar
  139. Lipowski Z (1990) Delirium: Acute confusional states. Oxford University Press, New York OxfordGoogle Scholar
  140. Lipowski ZJ (1975) Physical illness, the patient and his environment. In: Reiser M (ed) American handbook of psychiatry, vol 4. Basic Books, New York, pp 3–42Google Scholar
  141. Lipsey JR, Robinson RG, Pearlson GD et al. (1984) Nortriptyline treatment of post-stroke depression. Lancet i:297–300Google Scholar
  142. Lishman WA (1987, 31998) Organic psychiatry. The psychological consequences of cerebral disorder, 2nd edn. Blackwell, AbingdonGoogle Scholar
  143. Lloyd GG, Cawley RH (1978) Psychiatric morbidity in men one week after first acute myocardial infarction. Br J Med 2:1453–1454Google Scholar
  144. Lustman PJ, Griffith LS, Clouse RE et al. (1997) Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250PubMedGoogle Scholar
  145. Maricle RA, Hosenpud JD, Norman DJ et al. (1989) Depression in patients being evaluated for heart transplantation. Gen Hosp Psychiatry 11:418–424CrossRefPubMedGoogle Scholar
  146. Maguire P, Haddad P (1996) Psychological reactions to physical reactions. In: Guthrie E, Creed F (eds) Seminars in liaison psychiatry. Royal College of Psychiatrists, Gaskell Glasgow, pp 157–191Google Scholar
  147. Maguire GP, Julier DL, Hawton KE et al. (1974) Psychiatric morbidity and referral on two general medical wards. Br Med J:268–270Google Scholar
  148. Maguire GP, Lee EG, Bevington DJ et al. (1978) Psychiatric problems in the first year after mastectomy. Br Med J:963–965Google Scholar
  149. Manoach M, Varon D, Neumann M et al. (1989) The cardioprotective features of tricyclic antidepressants. Gen Pharmacol 20:269–275PubMedGoogle Scholar
  150. Masand P, Pickett P, Murray G (1991) Psychostimulants for secondary depression in medical illness. Psychosomatics 32:203–208PubMedGoogle Scholar
  151. Massie MJ, Holland JC (1990) Depression and the cancer patient. J Clin Psychiatry 51(Suppl 7):12–19PubMedGoogle Scholar
  152. Mayeux T (1990) Depression in the patient with Parkinson’s disease. J Clin Psychiatry 51:20–23PubMedGoogle Scholar
  153. Mayou RA, Sharpe M (1995) Psychiatric illness associated with physical disease. Baillieres Clin Psychiatry 1:201–223Google Scholar
  154. Mayou R, Hawton K, Feldman E (1988) What happens to medical patients with psychiatric disorder? J Psychosom Res 32:541–549CrossRefPubMedGoogle Scholar
  155. Meares RA, Mills JE, Horvath TB (1971) Amitriptyline and asthma. Med J Aust 2:25–28PubMedGoogle Scholar
  156. Moffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353PubMedGoogle Scholar
  157. Möller HJ (1996) Forschungsstandort Deutschland: Klinische Entwicklung neuer Antidepressiva. Psycho 22:147–157Google Scholar
  158. Montgomery SA (1995) Safety of mirtazapine: A review. Int Clin Psychopharmacol 10(Suppl 2):37–45PubMedGoogle Scholar
  159. Morris PL, Robinson RG, Andrzejewski P et al. (1993) Association of depression with 10 year post-stroke mortality. Am J Psychiatry 150:124–129PubMedGoogle Scholar
  160. Morrison MF, Kastenberg JS (1997) Differentiation of secondary from primary mood dissorders: Controversies and consensus. Semin Clini Neuropsychiatry 2:232–243Google Scholar
  161. Müller N, Kapfhammer HP, Spatz R, Hippius H (1995) Lithiumprophylaxe: Hohe Effizienz und geringes Risiko bei regelmäßiger Überwachung. Dtsch Ärztebl 92:A365–A369Google Scholar
  162. Murray GB, Shea V (1987) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47:258–260Google Scholar
  163. Noyes R, Hoehn-Saric R (1998) The anxiety disorders. Cambridge University Press, CambridgeGoogle Scholar
  164. Patten SB, Love EJ (1997) Drug-induced depression. Psychother Psychosom 66:63–73PubMedGoogle Scholar
  165. Pauli P, Wiedemann G, Dengler W et al. (1999) Anxiety in patients with an automatic implantable cardioverter defibrillator: What differentiates them from panic patients? Psychosom Med 61:69–76PubMedGoogle Scholar
  166. Perez-Stable WJ, Miranda J. Munoz RF et al. (1990) Depression in medical outpatients: Underrecognition and misdiagnosis. Arch Int Med 150:1983–1988Google Scholar
  167. Perkins D, Evans DL (1991) HIV-related major depression. Psychosomatics 32:451–454PubMedGoogle Scholar
  168. Popkin MK, Callies AL, Mackenzie TB (1985) The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 42:1160–1166PubMedGoogle Scholar
  169. Popkin MK, Callies AL, Lentz RD et al. (1988) Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing Type I diabetes mellitus. Arch Gen Psychiatry 45:64–68PubMedGoogle Scholar
  170. Popkin MK, Callies AL, Colon EA et al. (1990) Adjustment disorders in medically ill patients referred for consultation at a university hospital. Psychosomatics 31:410–414PubMedGoogle Scholar
  171. Prigerson HG, Shear K, Frank E et al. (1997) Traumatic grief: A case of loss-induced trauma. Am J Psychiatry 154:1003–1008PubMedGoogle Scholar
  172. Rabkin JG, Rabkin R, Harrison W et al. (1994) Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV infection. Am J Psychiatry 151:516–523PubMedGoogle Scholar
  173. Reding MJ, Orto LA, Winter SW et al. (1986) Antidepressant therapy after stroke. Arch Neurol 43:763–765PubMedGoogle Scholar
  174. Regan W, Margolin R, Mathew R (1989) Cardiac arrhythmia following rapid imipramine withdrawal. Biol Psychiatry 25:482–484CrossRefPubMedGoogle Scholar
  175. Reifler BV, Teri L, Raskind M et al. (1989) Double-blind trial with imipramine in Alzheimer’s disease patients with and without depression. Am J Psychiatry 146:45–49PubMedGoogle Scholar
  176. Richardson JL, Zarnegar Z, Bisno B, Levine A (1990) Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res 34:189–201CrossRefPubMedGoogle Scholar
  177. Ries RK, Gilbert DA, Katon W (1984) Tricyclic antidepressants in the therapy for peptic ulcer disease. Arch Intern Med 144:566–569CrossRefPubMedGoogle Scholar
  178. Rifkin A, Reardon G, Siris S et al. (1985) Trimipramin in physical illness with depression. J Clin Psychiatry 46:4–8PubMedGoogle Scholar
  179. Robertson MM, Trimble MR (1985) The treatment of depression in patients with epilepsy. J Affect Disord 9:127–136CrossRefPubMedGoogle Scholar
  180. Robertson MM, Trimble MR Townsend HRA (1987) Phenomenology of depression in epilepsy. Epilepsia 28:364–372PubMedGoogle Scholar
  181. Robbins E, Guze S (1972) Classification of affective disorders. In: Williams T, Katz M, Shields A (eds) Recent advantages in the psychobiolgy of the depressive illnesses. Government Printing Office, Washington/DCGoogle Scholar
  182. Robinson RG, Starr LB, Kubos KL et al. (1983) A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation. Stroke 14:736–741PubMedGoogle Scholar
  183. Robinson RG (1998) The clinical neuropsychiatry of stroke. Cognitive, behavioral and emotional disorders following vascular brain injury. Cambridge University Press, CambridgeGoogle Scholar
  184. Rodin G, Voshart K (1986) Depression in the medically ill. Am J Psychiatry 143:696–705PubMedGoogle Scholar
  185. Rodin R, Craven J, Littlefield C (1991) Depression in the medically ill. An integrated approach. Brunner/Mazel, New YorkGoogle Scholar
  186. Roose SP, Glassman A, Giardina E (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44:273–275PubMedGoogle Scholar
  187. Roose SP, Laghrissi-Thode F, Kennedy JS et al. (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279:287–291CrossRefPubMedGoogle Scholar
  188. Rotzinger S, Bourin M, Akimoto Y, Coutts RT, Baker GB (1999) Metabolism of some „second“-and „fourth“-generation antidepressants: Iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol 19(4):427–442CrossRefPubMedGoogle Scholar
  189. Rubey RN, Lydiard RB (1994) Psychopharmacology in the medically ill. In: Silver P (ed) Psychotropic drug use in the medically ill. Adv Psychosom Med, vol 21. Karger, Basel, pp 1–27Google Scholar
  190. Saran AS (1985) Depression after minor closed head injury. J Clin Psychiatry 46:335–338PubMedGoogle Scholar
  191. Satel SL, Nelson JC (1989) Stimulants in the treatment of depression. A critical overview. J Clin Psychiatry 50:241–249PubMedGoogle Scholar
  192. Satlin A (1998) The comorbidity of depression and medical illness in the elderly. In: Tohen M (ed) Comorbidity in affective disorders. Dekker, New York Basel, pp 157–178Google Scholar
  193. Schag CAC, Heinrich RL (1989) Anxiety in medical situations: Adult cancer patients. J Clin Psychology 45:20–27Google Scholar
  194. Schelling G, Scholl C, Haller M et al. (1998) Health-related quality of life and post-traumatic stress disorder in survivors of the acute respiratory distress syndrome (ARDS). Crit Care Med 26:651–659PubMedGoogle Scholar
  195. Schenker S, Bergstrom R, Wolen R et al. (1988) Fluoxetine disposition and elimination in cirrhosis. Pharmacol Ther 44:353–359Google Scholar
  196. Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493–1497PubMedGoogle Scholar
  197. Schiffer RB, Herndon RM, Rudick RA (1985) Treatment of pathological laughing and weeping with amitryptiline. N Engl J Med 312:1480–1482PubMedGoogle Scholar
  198. Schmale AH (1979) Reactions to illness. Psychiatr Clin North Am 2:321–330Google Scholar
  199. Schulberg HC, Saul M, McClelland M (1985) Assessing depression in primary medical and psychiatric practices.Arch Gen Psychiatry 12:1164–1170Google Scholar
  200. Schüßler G (1998) Krankheitsbewältigung und Psychotherapie bei körperlichen und chronischen Erkrankungen. Psychotherapeut 43:382–390Google Scholar
  201. Schwab JJ, McGinness NH, Marder L et al. (1966) Evaluation of anxiety in medical patients. J Chron Dis 19:1049–1057CrossRefPubMedGoogle Scholar
  202. Schwartz JA, Speed N, Clavier E (1988) Tricyclic antidepressants in treatment of the medically ill: The value of psychiatric consultation. Int J Psychiatry Med 18:235–241PubMedGoogle Scholar
  203. Schwartz JA, Speed N, Beresford TP (1989) Antidepressants in the medically ill: Prediction of benefits. Int J Psychiatry Med 19:363–369PubMedGoogle Scholar
  204. Secor JW, Schenker S (1987) Drug metabolism in patients with liver disease. Adv Intern Med 32:379–406PubMedGoogle Scholar
  205. Sellers EM, Bendayan R (1987) Pharmacokinetics of psychotropic drugs in selected patient populations. In: Meltzer HY (ed) Psychopharmacology: The third generation of progress. Raven, New York, pp 1397–1406Google Scholar
  206. Shakin EJ, Holland J (1988) Depression and pancreatic cancer. J Pain Symptom Manage 3:194–198CrossRefPubMedGoogle Scholar
  207. Sharpe M, Hawton K, Seagrott V et al. (1994) Depressive disorders in long-term survivors of stroke. Br J Psychiatry 164:380–386PubMedGoogle Scholar
  208. Sherbourne CD, Jackson CA, Meredith LS et al. (1996) Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med 5:27–34CrossRefPubMedGoogle Scholar
  209. Sliman RJ, Donahue TA, Jarjoura D et al. (1992) Recognition of depression by internal medicine residents. J Community Health 17:143–152CrossRefPubMedGoogle Scholar
  210. Sonino N, Fava GA, Belluardo P et al. (1993) Course of depression in Cushing’s syndrome: Response to treatment and comparison with Graves’ disease.Horm Res 39:202–206PubMedGoogle Scholar
  211. Spiegel D (1991) Psychosocial aspects of cancer.Curr Opin Psychiatry 4:889–897Google Scholar
  212. Spiegel D (1994) Krebs und Depression. Verhaltenstherapie 4:81–88Google Scholar
  213. Spiegel D, Lazar SG (1997) The need for psychotherapy in the medically ill. Psychoana Inquiry (Suppl) 17:45–50Google Scholar
  214. Spiegel D, Bloom JR, Kraemer HC et al. (1989) Effect of psychological treatment on survival of patients with metastatic breast cancer. Lancet ii:888–889Google Scholar
  215. Starkman MN, Zelnik TC, Nesse TC et al. (1985) Anxiety in patients with pheochromocytomas. Arch Intern Med 145:248–252CrossRefPubMedGoogle Scholar
  216. Starkstein SE, Robinson RG (1989) Affective disorder and cerebral vascular disease. Br J Psychiatry 154:170–182PubMedGoogle Scholar
  217. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG (1990) Depression in parkinson’s disease. J Nerv Ment Dis 178:27–31PubMedGoogle Scholar
  218. Stefanek ME, Shaw A, DeGeorge D et al. (1989) Illness-related worry among cancer patients: Prevalence, severity and content. Cancer Invest 7:365–371PubMedGoogle Scholar
  219. Stoudemire A, Atkinson P (1988) Use of cyclic antidepressants in patients with cardiac conduction disturbances. Gen Hosp Psychiatry 10:389–397CrossRefPubMedGoogle Scholar
  220. Stoudemire A, Hales RE (1991) Psychological and behavioral factors affecting medical conditions and DSM-IV. Psychosomatics 32:5–13PubMedGoogle Scholar
  221. Stoudemire A, Moran MG, Fogel BS (1990) Psychotropic use in the medically ill: Part I. Psychosomatics 31:377–391PubMedGoogle Scholar
  222. Stoudemire A, Fogel BS, Gulley LR (1991) Psychopharmacology in the medically ill: An update. In: Stoudemire A, Fogel BS (eds) Medical psychiatric practice. American Psychiatric Press, Washington/DC London, pp 29–97Google Scholar
  223. Strian F, Ploog D (1988) Anxiety related to nervous system dysfunction. In: Noyes R, Roth M, Burrows GD (eds) Handbook of anxiety 2. Elsevier, Amsterdam, pp 431–475Google Scholar
  224. Surman O (1991) Hemodialysis and renal transplantation. In: Cassem N (ed) Massachusetts General Hospital Handbook of General Hospital Psychiatry, 3rd edn. Mosby Year Book, St. Louis/MO, pp 401–430Google Scholar
  225. Tarter RE, Switala J, Carra J et al. (1987) Inflammatory bowel disease: Psychiatric status of patients before and after disease onset. Int J Psychiatry Med 17:173–181PubMedGoogle Scholar
  226. Thompson WL, Thompson TL (1984) Treating depression in asthmatic patients. Psychosomatics 25:809–812PubMedGoogle Scholar
  227. Thompson WL, Thompson TL (1993) Pulmonary disease. In: Stoudemire A, Fogel B (eds) Psychiatric care of the medical patient. Oxford University Press, New York, pp 591–610Google Scholar
  228. Troy S, Schultz R, Parker V et al. (1994) The effect of renal disease on the disposition of venlafaxine. Clin Pharmacol Ther 56:14–21PubMedGoogle Scholar
  229. Trzepacz PT, McCue M, Klein I et al. (1988) A psychiatric and neuropsychological study of patients with untreated Graves’ disease. Gen Hosp Psychiatry 10:49–55CrossRefPubMedGoogle Scholar
  230. Trzepacz PT, Brenner R, van Thiel DH (1989) A psychiatric study of 247 liver transplantation candidates. Psychosomatics 30:147–153PubMedGoogle Scholar
  231. Veith RC, Raskind MA, Caldwell JH et al. (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306:954–959PubMedGoogle Scholar
  232. Wells KG, Golding JM, Burnham MA (1988) Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 145:976–981PubMedGoogle Scholar
  233. Wells KB, Golding JM, Burnam MA (1989) Affective substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry 11:320–327PubMedGoogle Scholar
  234. Whitlock FA (1982) Symptomatic affective disorders. Academic Press, SydneyGoogle Scholar
  235. Wilson RCD (1974) Antiasthmatic effect of amitriptyline. Can Med Assoc J 3:212Google Scholar
  236. Winokur G (1990) The concept of secondary depression and its relationship to comorbidity. Psychiatr Clin North Am 13:567–583PubMedGoogle Scholar
  237. Winokur G, Black DW, Nashrallah A (1988) Depressions secondary to other psychiatric disorders and medical illnesses. Am J Psychiatry 145:233–237PubMedGoogle Scholar
  238. Wolfersdorf M (1993) Suizidalität bei Tumor-und anderen körperlichen Erkrankungen. In: Staab HJ, Ludwig M (Hrsg) Depression bei Tumorpatienten. Thieme, Stuttgart New York, S 49–67Google Scholar
  239. Yates WR, Bowers WA (2000) Cognitive therapy in the medicalpsychiatric patient. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient. 2nd edn. Oxford University Press, Oxford, pp 51–60Google Scholar
  240. Zaubler T, Katon W (1998) Panic disorder in the general medical setting. J Psychosom Res 44:25–42CrossRefPubMedGoogle Scholar
  241. Zisook S, Paulus M, Shuchter SR, Judd LL (1997) The many faces of depression following spousal bereavement. J Affect Disord 45:85–95CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2003

Authors and Affiliations

  • H.-P. Kapfhammer

There are no affiliations available

Personalised recommendations